Donaldson Company, Inc. provided earnings guidance for the Fiscal Year 2024. For the year, the company expects full-year EPS to be between $3.14 and $3.30, Sales are expected to increase between 3% and 7% year over year, with a pricing benefit of approximately 2% and a currency translation tailwind of roughly 1%. Operating margin is expected to be between 14.7% and 15.3%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.9 USD | -0.48% | +3.74% | +14.61% |
Apr. 29 | Donaldson Agrees to Acquire 49% Stake in Medica | MT |
Apr. 19 | Donaldson Company, Inc. made an offer to acquire Medica S.p.A. for ?22.9 million. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.61% | 9.02B | |
+36.99% | 2.38B | |
-10.87% | 1.04B | |
+15.98% | 822M | |
-6.05% | 777M | |
+14.48% | 654M | |
+12.66% | 651M | |
-11.69% | 625M | |
-3.85% | 584M | |
+13.21% | 565M |
- Stock Market
- Equities
- DCI Stock
- News Donaldson Company, Inc.
- Donaldson Company, Inc. Provides Earnings Guidance for the Fiscal Year 2024